Getting therapies to the brain has challenged researchers for decades, driving interest in alternative drug delivery technologies. Through its proprietary intranasal platform, @OragenicsNews is developing brain-targeted therapeutics designed to deliver investigational therapies directly to the central nervous system, with ONP-002 leading its clinical pipeline. $OGEN
published
Getting therapies to the brain has challenged researchers for decades, driving interest in alternative drug delivery technologies. Through its proprietary intranasal platform, @OragenicsNews is developing brain-targeted therapeutics designed to deliver invest
$OGEN
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.